Jesper V Olsen Selected Research

Jesper V Olsen Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 01/2003
3	Neuroblastoma 04/2021 - 04/2015
3	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2013
3	Genomic Instability 01/2018 - 03/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2020
2	Heart Diseases (Heart Disease) 01/2021 - 06/2013
2	Fanconi Anemia (Fanconi's Anemia) 01/2019 - 01/2015
2	Adenocarcinoma 01/2019 - 09/2014
2	Obesity 06/2017 - 12/2012
2	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2014
2	Inflammation (Inflammations) 01/2016 - 09/2014
1	Multiple System Atrophy 06/2022
1	Parkinsonian Disorders (Parkinsonism) 06/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Body Remains 01/2019
1	Calculi (Calculus) 11/2018
1	Intellectual Disability (Idiocy) 01/2018
1	Communicable Diseases (Infectious Diseases) 06/2017
1	Starvation 06/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Periodontitis 01/2016
1	Dental Caries (Decay, Dental) 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2014
1	Periodontal Diseases (Periodontal Disease) 04/2014
1	Colorectal Neoplasms (Colorectal Cancer) 09/2013
1	Down Syndrome (Down's Syndrome) 06/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2013
1	Hypertension (High Blood Pressure) 06/2013
1	Cardiac Arrhythmias (Arrythmia) 06/2013
1	Narcolepsy 08/2012
1	Alcoholism (Alcohol Abuse) 08/2012
1	Hypersensitivity (Allergy) 04/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2010
1	Carcinogenesis 01/2010

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2008
10	Phosphotransferases (Kinase)IBA 01/2022 - 07/2009
7	ProteomeIBA 06/2022 - 02/2007
6	Pharmaceutical PreparationsIBA 01/2017 - 01/2009
5	UbiquitinIBA 04/2021 - 03/2014
3	Tyrosine (L-Tyrosine)FDA Link 10/2019 - 06/2013
3	Protein Kinases (Protein Kinase)IBA 07/2009 - 08/2008
2	Complement System Proteins (Complement)IBA 06/2022 - 01/2016
2	Drug CombinationsIBA 01/2022 - 01/2017
2	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 07/2009
2	Transcription Factors (Transcription Factor)IBA 11/2018 - 01/2017
2	Peptides (Polypeptides)IBA 12/2012 - 12/2011
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2021
1	Ligases (Synthetase)IBA 04/2021
1	3-hydroxycyclopent-1-enecarboxylic acidIBA 01/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021
1	ChromatinIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 11/2018
1	indolepropanol phosphate (IPP)IBA 11/2018
1	NVP-TAE684IBA 11/2018
1	ceritinibIBA 11/2018
1	CrizotinibIBA 11/2018
1	Anaplastic Lymphoma KinaseIBA 11/2018
1	Tyrosine Kinase InhibitorsIBA 11/2018
1	lorlatinibIBA 11/2018
1	Insulin Receptor Substrate ProteinsIBA 11/2018
1	Indicators and Reagents (Reagents)IBA 06/2017
1	Eosinophil PeroxidaseIBA 06/2017
1	midostaurinIBA 01/2017
1	Deubiquitinating EnzymesIBA 01/2017
1	EWS-FLI fusion proteinIBA 01/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	TropomyosinIBA 04/2015
1	Nerve Growth Factor (NGF)IBA 04/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2015
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2015
1	EnzymesIBA 01/2015
1	Carrier Proteins (Binding Protein)IBA 01/2015
1	Biological ProductsIBA 09/2014
1	GlycosyltransferasesIBA 09/2014
1	Polysaccharides (Glycans)IBA 09/2014
1	Immunologic Factors (Immunomodulators)IBA 04/2014
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 09/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2013
1	Topoisomerase InhibitorsIBA 09/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 06/2013
1	Secretin FDA Link 12/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2012
1	NeurotensinIBA 12/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2012
1	Therapeutic UsesIBA 08/2012
1	DNA (Deoxyribonucleic Acid)IBA 04/2012
1	Type 1 Angiotensin ReceptorIBA 07/2010
1	GTP-Binding Proteins (G-Protein)IBA 07/2010

Therapy/Procedure

3	Therapeutics 04/2021 - 01/2017
1	Castration 01/2019
1	Drug Therapy (Chemotherapy) 09/2013